Amsacrine Injection

Function and indication: This product is effective for acute leukemia and malignant lymphoma. There is no obvious cross-resistance to patients who are resistant to anthracyclines and cytarabine, and it is still effective for some patients.
Usage and dosage: The dosage and usage of different dosage forms and specifications of this product may vary. Please read the specific drug instructions for use, or follow the doctor’s advice. Amsacrine injection: 1. Acute leukemia: 75mg/m2 per body surface area, once a day, intravenous injection or drip, for 7 consecutive days, the maximum tolerated dose is 150mg/m2. 2. Solid tumors: 75-120mg/m2 per body surface area, once every 3-4 weeks.
Adverse reactions: 1. Mainly bone marrow suppression, which is a dose-limiting toxicity. When the dosage reaches 90-120mg/m2, thrombocytopenia and leukopenia may occur. 2. Common gastrointestinal reactions are related to the dose. Low to moderate nausea and vomiting often occur. When